NCT02384538View on ClinicalTrials.gov

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Erosive Hand Osteoarthritis
Interventions
BIOLOGICAL

ABT-981

ABT-981 administered by subcutaneous injection

BIOLOGICAL

Placebo for ABT-981

Placebo for ABT-981 administered by subcutaneous injection

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY